Can I take Bactrim (trimethoprim‑sulfamethoxazole) and Keflex (cephalexin) for a 14‑day course to treat a wound infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Combination Therapy with Bactrim and Keflex for Wound Infection

Using both Bactrim (trimethoprim-sulfamethoxazole) and Keflex (cephalexin) together for 14 days is not recommended and provides no additional benefit over monotherapy for wound infections. Choose one antibiotic based on the specific characteristics of your wound infection.

Why Combination Therapy Is Not Indicated

The evidence clearly demonstrates that adding TMP-SMX to cephalexin does not improve cure rates:

  • For wound infections specifically: A randomized trial showed clindamycin and TMP-SMX alone produced equivalent cure rates (92.1% vs 91.9%) in uncomplicated wound infections, with no role for combination therapy 1

  • For cellulitis: Two high-quality randomized trials found that cephalexin plus TMP-SMX was not superior to cephalexin alone. The per-protocol cure rates were actually slightly lower with combination therapy (83.5% vs 85.5%) 2, and another trial showed no benefit (85% vs 82% cure rates) 3

How to Choose the Right Single Agent

For Purulent Wound Infections (with pus/drainage):

  • Use TMP-SMX alone or clindamycin
  • IDSA guidelines specifically recommend TMP-SMX, clindamycin, or doxycycline when MRSA is suspected 4
  • MRSA is found in 40-62% of purulent wound cultures 1, 5

For Non-purulent Wound Infections (no pus):

  • Use cephalexin alone (500 mg four times daily)
  • Covers methicillin-susceptible Staphylococcus aureus (MSSA) and streptococci
  • IDSA guidelines support cephalexin for non-purulent infections 4

Duration: 7 Days, Not 14 Days

The standard duration is 7 days, not 14 days 4, 2, 1. IDSA guidelines recommend 7-day regimens for skin and soft tissue infections 4. The clinical trials demonstrating efficacy all used 7-day courses 2, 3, 1.

Critical Safety Concerns with Combination Therapy

Using both drugs simultaneously increases risks without benefit:

  • Drug interactions: Bactrim inhibits CYP2C8, CYP2C9, and OCT2 transporters, potentially affecting other medications 6
  • Electrolyte abnormalities: TMP-SMX can cause hyperkalemia and hyponatremia 6
  • Increased adverse events: Higher pill burden without improved outcomes
  • Antibiotic resistance: Unnecessary broad-spectrum coverage promotes resistance 6, 7

Practical Algorithm

  1. Assess for purulence: Is there pus, drainage, or abscess?

    • Yes → TMP-SMX DS (800/160 mg) twice daily for 7 days
    • No → Cephalexin 500 mg four times daily for 7 days
  2. Consider MRSA risk factors: Previous MRSA infection, high local prevalence, injection drug use

    • Present → TMP-SMX preferred
    • Absent → Cephalexin appropriate
  3. Ensure adequate drainage: Incision and drainage is essential for purulent infections; antibiotics are adjunctive 4

Common Pitfalls to Avoid

  • Don't prescribe combination therapy reflexively thinking "more is better"—the evidence shows no benefit 2, 3
  • Don't extend to 14 days routinely—7 days is standard and evidence-based 4
  • Don't use TMP-SMX for non-purulent cellulitis alone—it lacks adequate streptococcal coverage 8
  • Monitor for recurrence: TMP-SMX had higher recurrence rates (7.1%) compared to clindamycin (2.0%) in one trial 1

Bottom line: Select ONE antibiotic based on wound characteristics, use for 7 days, and ensure proper wound care including drainage if indicated.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.